-
Report: Cancer Incidence Rising in Adults Younger Than 50
Dr. John Marshall shares his observations about the rise in early-onset Colorectal Cancer.
Category: News
-
Dr He on the Evaluation of Camrelizumab Plus Rivoceranib in Unresectable HCC
Aiwu Ruth He, MD, PhD, discusses the evaluation of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma.
Category: News
-
People who got colon cancer in their 20s or 30s describe what it was like and the signs that were ignored
Dr. Marshall is interviewed discussing symptoms of colorectal cancer
Category: News
-
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
John Marshall, MD, director of the Ruesch Center, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.
Category: News
-
FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC
John L. Marshall, MD, sheds light on the significance of the FDA approval of fruquintinib for patients with heavily pretreated metastatic colorectal cancer and discusses the efficacy and safety data from the FRESCO and FRESCO-2 trials that supported the decision in this population.
Category: News
-
Luminary Awards Highlight Exemplary Work of Experts in GI Cancers
The Luminary Awards in GI Cancers are designed to highlight the lifetime achievements of individuals who have dedicated their careers to expanding the knowledge of the GI cancer community.
Category: News
-
Mixed CRC Screening Messaging. Confusing? Some Docs Think So
Dr. Marshall discusses updated colorectal cancer screening guidance from the American College of Physicians
Category: News
-
Dr. Marshall discusses updates for the management of patients with metastatic colorectal cancer
Dr. Marshall joins experts for an overview on metastatic colorectal cancer, the latest advancements in treatments for metastatic colorectal cancer, and the future considerations for metastatic colorectal cancer.
Category: News
-
Ivana Peran, PhD Ruesch Collaborator Granted PanCAn Career Development Funding
“Role of Stromal Cadherin 11 in Chemotherapy Response in Pancreatic Cancer”. This grant is awarded to researchers new in the field who we hope will go on to make groundbreaking discoveries.
Category: News
-
Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Category: News